Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
10/2006
10/19/2006US20060234220 Novel n-acetylglucosamine transferase, nucleic acid encoding the same, antibody against the same and use thereof for diagnosing cancer or tumor
10/19/2006US20060234218 P450 proteins
10/19/2006US20060234217 Nucleic acid encodes a heat labile alkaline phosphatase, or the complementary sequence
10/19/2006US20060234216 Nucleotide sequences coding polypeptide for use in the treatment of transport protein and hearing defect
10/19/2006US20060234212 Hepatitis-B viral variants with reduced susceptibility to nucleoside analogs and uses thereof
10/19/2006US20060234211 Arterivirus (RNA enveloped virus); polypeptides with sensitivity and specificity; decreasing the incidence of false positives in a diagnostic assay
10/19/2006US20060233839 Novel compounds
10/19/2006US20060233827 85kDa neisserial antigen
10/19/2006US20060233826 Nucleotide sequences coding chlamydial membrane protein for use in generating neutralizing antibody which prevents micoorganismal infection
10/19/2006US20060233822 Hepatitis e virus monoclonal antibodies or the binding fragments of it and the use thereof
10/19/2006US20060233821 Compositions and methods for the inhibition of membrane fusion by paramyxoviruses
10/19/2006US20060233818 Organic compounds
10/19/2006US20060233808 Peptabody for cancer treatment
10/19/2006US20060233803 treating an inflammatory disorder characterized by elevated expression of the polypeptide of SEQ ID NO: 32 in human, comprising administering an immunoadhesin comprising an extracellular domain sequence of the polypeptide; rheumatoid arthritis, pneumonia, chronic asthma, chronic hepatitis, osteoarthritis
10/19/2006US20060233802 Tumour necrosis factor binding ligands
10/19/2006US20060233801 TGF- beta binding proteins which can be utilized to increase bone mineralization, and thus may be utilized in treating osteopenia, osteoporosis and bone fractures
10/19/2006US20060233792 novel tumor necrosis factor receptor (TRAIN-R) for treating inflammatory bowel disease and arthritic condition; antiinflammatory agents
10/19/2006US20060233787 Human cd3-specific antibody with immunosuppressive properties
10/19/2006US20060233782 Polypeptide; a deletion mutant of chondroitinase ABC Type I truncated by a deletion; retains its proteoglycan degrading activity; neurological functional recovery after central nervous system injury or disease
10/19/2006US20060233749 Interleukin-19
10/19/2006US20060233747 Polymer-modified synthetic proteins
10/19/2006US20060233746 N-terminally chemically modified protein compositions and methods
10/19/2006US20060233744 Orthogonal tRNA synthetase that aminoacylates with reduced efficiency; lower km and recognizes selector codon in mRNA
10/19/2006CA2604135A1 Pop2 nfkb-inhibiting polypeptides, nucleic acids and methods of use
10/19/2006CA2604095A1 Methods for determining sequence variants using ultra-deep sequencing
10/19/2006CA2603842A1 Rnai therapeutic for respiratory virus infection
10/18/2006EP1712557A1 New s-adenosyl-L-methionine analogues with extended activated groups for transfer by methyltransferases
10/18/2006EP1711634A2 Naphthalimide dosing by n-acetyl transferase genotyping
10/18/2006EP1711632A2 Diagnostic test for parkinson's disease
10/18/2006EP1711621A2 Primers, methods and kits for amplifying or detecting human leukocyte antigen alleles
10/18/2006EP1711614A2 Ap2 domain transcription factor odp2 (ovule development protein 2) and methods of use
10/18/2006EP1711613A2 Gene silencing by using micro-rna molecules
10/18/2006EP1711610A2 HETERODIMERIC FOLLICLE STIMULATING HORMONE-Fc (FSH-Fc) FUSION PROTEINS FOR THE TREATMENT OF INFERTILITY
10/18/2006EP1711533A2 Methods of producing peptides/proteins in plants and peptides/proteins produced thereby
10/18/2006EP1711524A2 Polynucleotide encoding a novel human g-protein coupled receptor variant of the relaxin receptor, hgprbmy5v1, and variants thereof
10/18/2006EP1711516A1 Hcv rna-dependent rna polymerase
10/18/2006EP1711510A2 Rnai therapeutics for treatment of eye neovascularization diseases
10/18/2006EP1711509A2 Inhibition of bright function as a treatment for excessive immunoglobulin production
10/18/2006EP1711172A2 Compositions and methods for combined therapy of disease
10/18/2006EP1711048A1 Methods of expressing heterologous protein in plant seeds using monocot non seed-storage protein promoters
10/18/2006EP1673382A4 Adrenergic receptor snp for improved milking characteristics
10/18/2006EP1576190A4 Methods and nucleic acids for the analysis of cpg dinucleotide methylation status associated with the calcitonin gene
10/18/2006EP1552022A4 Identification of oligonucleotides for the capture, detection and quantitation of hepatitis a viral nucleic acid
10/18/2006EP1358332B1 A serpin in bifidobacteria
10/18/2006EP0948511B1 Chemical synthesis of nucleosides analogs and their incorporation into polynucleotides
10/18/2006CN1849396A Improved inhibitor nucleic acids
10/18/2006CN1849337A Compositions and methods for treating cancer using IGSF9 and LIV-1
10/18/2006CN1849329A CNGH0010 specific polynucleotides, polypeptides, antibodies, compositions, methods and uses
10/18/2006CN1849134A Functional influenza virus-like particles(VLPs)
10/18/2006CN1849069A Modified oligonucleotides for telomerase inhibition
10/18/2006CN1847257A Mononucleotide polymorphism related to hypertrophic degree of central muscle of hypertrophic cardiomyopathy and its use
10/18/2006CN1847256A Antiviral prepn containing both CpG single-strand deoxyoligonucleotide and ribavirin
10/18/2006CN1280413C Promoter for regulating and controlling lignin to synthesize relevant enzyme gene and application
10/18/2006CN1280303C Artificial composite deoxygenation oligonucleotide with CpG single chain being contained, and effect of anti SARS virus
10/17/2006USRE39355 Fusion protein with amino acid sequence of mature human insulin-like growth factor; synthesized in recombinant cell culture by host cells transformed with expression vectors; genetic engineering
10/17/2006USRE39352 Creatine amidinohydrolase, production thereof and use thereof
10/17/2006US7122723 Plant recombination proteins
10/17/2006US7122659 Assay methods and systems
10/17/2006US7122657 UDP-glucose aglycon-glucosytransferase
10/17/2006US7122656 MyD88S allows activation of JNK and AP-1, whereas the NF- kappa B pathway is completely blocked; used to obtain immunosuppression (e.g., in the case of transplantation); modulation of the expression of MyD88S can regulate the cellular responses to LPS and other immunological stimuli
10/17/2006US7122655 Compositions involving M-RIP, and related methods for screening for anti-hypertensive agents, and uses thereof
10/17/2006US7122653 Nucleotide sequences coding polypeptide for use in the detection, diagnosis, prevention and classification of prostate tumors
10/17/2006US7122652 Isolated polynucleotide encoding a variant human pregnane X receptor (hPXR) polypeptide or fragment; detection and genotyping of hPXR alleles in humans, homozygous as well as heterozygous, alleles of the hPXR gene
10/17/2006US7122651 Nucleic acid molecules encoding opioid growth factor receptors
10/17/2006US7122650 Comprises nucleotide sequences coding polypeptide which inactivates corticotropin-releasing factor (CRF) for use as to in treatment of anxiety and depression
10/17/2006US7122649 Derivatized oligonucleotides having improved uptake and other properties
10/17/2006US7122648 Isolated nucleic acids; binding to antibody; diagnosis of muscular disorders
10/17/2006US7122647 Preparing solid support comprising immobilized biopolymers for detecting, measuring, separating and/or assaying DNA or proteins in a sample
10/17/2006US7122646 Multivalent and multispecific binding proteins, their manufacture and use
10/17/2006US7122644 Methods and compositions for inhibiting neoplastic cell growth
10/17/2006US7122630 Proteins in cell cycle regulation; cell cycle protein binds to SYK kinase
10/17/2006US7122621 Contains domains capable of forming amphipathic alpha helix, for cell lysis; site-directed mutagenesis; for treatment of leukemia or stomach carcinoma
10/17/2006US7122527 Use of antisense oligonucleotides to inhibit the expression of human Akt-1
10/17/2006US7122378 Producing a series of sequential cross-sectional slices of a bundle of adhered linearly-aligned fibers, determining the two-dimensional coordinates of each fiber unit within a fiber alignment slice, determining the two-dimensional coordinates of each fiber unit
10/17/2006US7122375 Relasted to differentiation and maintenance of multicellular organisms
10/17/2006US7122368 Point mutations; recombinant vectors/molecular targets; transcription factors
10/17/2006US7122367 Can be used to transform oil crop plants
10/17/2006US7122365 Enzymatic polypeptide for use in processing starch
10/17/2006US7122363 Comprises nucleotide sequences coding cyclic nucleotide phosphodiesterases for treatment of cardiovascular, depressive and vascular disorders; cardiotonic agents; antidepressants; antihypertensives; antithrombotics
10/17/2006US7122362 For diagnosing, treating, or preventing disorders associated with aberrant expression of human phosphodiesterases
10/17/2006US7122361 Compositions employing a novel human kinase
10/17/2006US7122360 Polypeptides, polynucleotides and uses thereof
10/17/2006US7122354 Therapy for Fabry's disease; genetic engineering; cloning; gene therapy
10/17/2006US7122350 Promoters provide a sterically repressed promoter in which an additional lac operator site is inserted between the -10 and -35 elements, where it can interfere sterically with binding of RNA Polymerase and thereby prevent the assembly of a poised transcriptional complex
10/17/2006US7122348 Adeno-associated viral deletion rep protein comprising functional nuclear localization sequence for use delivery of gene products to preferential intracellular locations
10/17/2006US7122346 Genetic engineering in prokaryotic cells; diagnosis of autoimmune disease using antibodies
10/17/2006US7122345 Used to treat blood, brain, urogenital, nervous system, sexual, bone, cardiovascular, gastrointestinal, skin disorders, cancer, bacterial/viral/fungi infections
10/17/2006US7122316 Combining mixture of RNA polymerase and reversible inhibitor of RNA polymerase (reversible inhibitor does not hybridize to a target nucleic acid sequence), with sample suspected to contain target nucleic acid, exposing to amplification
10/17/2006US7122311 Diagnosing respiratory disorder; obtain cells, monitor expression of marker gene, determine sequence, compare to control, detect polymorphism in polypeptide or nucleotide, presence of polymorphism indicates respiratory disorders
10/17/2006US7122310 Generation of self-assembling sequences; obtain oligonucleotide sequences, denature, incubate with probes, allow hybridization, recover products
10/17/2006US7122309 High throughput screening assay for detecting a DNA sequence
10/17/2006US7122304 Methods for the storage and synthesis of nucleic acids using a solid support
10/17/2006US7122303 Arrays comprising background features that provide for a measure of a non-specific binding and methods for using the same
10/17/2006US7122302 Method for determining early HCV seroconversion
10/17/2006US7122196 Compounds and methods for diagnosis of tuberculosis
10/17/2006US7122180 DNA vectors containing mutated HIV proviruses
10/12/2006WO2006107686A1 Methods, compositions, and kits for detecting nucleic acids in a single vessel
10/12/2006WO2006106521A2 Hydrophilic dispersions of nanoparticles of inclusion complexes of macromolecules
10/12/2006WO2006106519A2 Hydrophilic dispersions of nanoparticles of inclusion complexes of amorphous compounds
10/12/2006WO2006071840A8 Formulations of human growth hormone comprising a non-naturally encoded amino acid